国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
21期
3333-3335
,共3页
周文涛%何国%张文仕%曾婷苑%陈秀凤
週文濤%何國%張文仕%曾婷苑%陳秀鳳
주문도%하국%장문사%증정원%진수봉
纳米银抗菌凝胶%重组人表皮细胞生长因子%压疮创面
納米銀抗菌凝膠%重組人錶皮細胞生長因子%壓瘡創麵
납미은항균응효%중조인표피세포생장인자%압창창면
Nanometer silver antibacterial gel%Recombinant human epidermal growth factor%Bedsore wound
目的 探讨纳米银抗菌凝胶联合重组人表皮细胞生长因子(rhEGF)在治疗压疮创面中的应用价值.方法 将我院2009年9月至2013年6月期间住院治疗的68例压疮患者按不同治疗方式随机分为对照组(给予常规治疗)和实验组(纳米银抗菌凝胶+重组人表皮细胞生长因子),治疗14 d后比较两组患者治疗效果.结果 实验组患者治疗总有效率达到91.1%,明显高于对照组患者(73.5%)(p<0.05);实验组患者创面愈合时间和皮肤愈合时间均明显少于对照组患者(P<0.05).结论 纳米银抗菌凝胶联合rhEGF治疗压疮创面效果显著,值得临床推广应用.
目的 探討納米銀抗菌凝膠聯閤重組人錶皮細胞生長因子(rhEGF)在治療壓瘡創麵中的應用價值.方法 將我院2009年9月至2013年6月期間住院治療的68例壓瘡患者按不同治療方式隨機分為對照組(給予常規治療)和實驗組(納米銀抗菌凝膠+重組人錶皮細胞生長因子),治療14 d後比較兩組患者治療效果.結果 實驗組患者治療總有效率達到91.1%,明顯高于對照組患者(73.5%)(p<0.05);實驗組患者創麵愈閤時間和皮膚愈閤時間均明顯少于對照組患者(P<0.05).結論 納米銀抗菌凝膠聯閤rhEGF治療壓瘡創麵效果顯著,值得臨床推廣應用.
목적 탐토납미은항균응효연합중조인표피세포생장인자(rhEGF)재치료압창창면중적응용개치.방법 장아원2009년9월지2013년6월기간주원치료적68례압창환자안불동치료방식수궤분위대조조(급여상규치료)화실험조(납미은항균응효+중조인표피세포생장인자),치료14 d후비교량조환자치료효과.결과 실험조환자치료총유효솔체도91.1%,명현고우대조조환자(73.5%)(p<0.05);실험조환자창면유합시간화피부유합시간균명현소우대조조환자(P<0.05).결론 납미은항균응효연합rhEGF치료압창창면효과현저,치득림상추엄응용.
Objective To investigate the application of nanometer silver antibacterial gel combined with recombinant human epidermal growth factor (rhEGF) in the treatment of bedsore wound.Methods 68 cases of bedsore wound in our hospital were randomly divided into control group and experimental group from September 2009 to June 2013.Control group received conventional therapy,while experimental group received nanometer silver antibacterial gel + rhEGF.The efficacy of two groups was compared after 14 days' treatment.Results The total effective rate of experimental group was 91.1%,significantly higher than 73.5% of control group (P < 0.05).The wound healing time and skin healing time of experimental group were shorter than those of control group (P < 0.05).Conclusion Nanometer silver antibacterial gel combined with recombinant human epidermal growth factor has a significant effect on bedsore wound,which is worthy of clinical application.